Molecular genotyping in medullary thyroid cancer

被引：2
|
作者：
Newbold, Kate [1 ,2 ]
机构：
[1] Royal Marsden NHS Fdn Trust Hosp, London, England
[2] Royal Marsden NHS Fdn Trust Hosp, Consultant Clin Oncologist, Fulham Rd, London SW3 6JJ, England
来源：
CURRENT OPINION IN ONCOLOGY | 2023年 / 35卷 / 01期
关键词：
medullary thyroid cancer; rearranged during transfection; ACQUIRED-RESISTANCE; RET PROTOONCOGENE; RAS MUTATIONS; CARCINOMA; ACTIVATION; SELPERCATINIB; CABOZANTINIB;
D O I：
10.1097/CCO.0000000000000915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of reviewThere has been a significant advance in our understanding of the molecular biology of medullary thyroid cancer (MTC) alongside progress in the development of targeted therapies including multikinase and specific rearranged during transfection inhibitors.Recent findingsThis review will examine the latest data investigating the impact of the genomics of MTC on the prediction of the natural history of an individual's disease and the determination, selection and timing of treatment interventions.Recent advances in genotyping in MTC and the development of targeted therapies have impacted on the clinical management of both sporadic and hereditary MTC.
引用
收藏
页码：10 / 14
页数：5
相关论文
共 50 条
  • [31] Molecular targets in medullary thyroid carcinoma
    Moore, Sam W.
    GENE THERAPY AND MOLECULAR BIOLOGY, 2008, 12B : 181 - 188
  • [32] Molecular Diagnosis of Medullary Thyroid Carcinoma
    Goel, Kanika
    Silverman, Jan F.
    Narick, Christina
    Finkelstein, Sydney
    LABORATORY INVESTIGATION, 2018, 98 : 231 - 231
  • [33] Molecular profiles in medullary thyroid carcinomas
    Cozaru, G. C.
    Aschie, M.
    Mitroi, A. F.
    Brinzan, C.
    Baltatescu, G. I.
    Nicolau, A.
    Enciu, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 469 - 470
  • [34] Molecular Diagnosis of Medullary Thyroid Carcinoma
    Goel, Kanika
    Silverman, Jan F.
    Narick, Christina
    Finkelstein, Sydney
    MODERN PATHOLOGY, 2018, 31 : 231 - 231
  • [35] Medullary and non-medullary thyroid cancer in a family
    Ardern-Jones, A
    Harvey, RJ
    Wilson, P
    Sharma, AK
    Murday, V
    Harmer, C
    Houlston, RS
    ACTA ONCOLOGICA, 2004, 43 (07) : 680 - 681
  • [36] THYROID CANCER WITH AMYLOID STROMA OR MEDULLARY CANCER OF BODY OF THYROID
    VETEL, JM
    GAZETTE MEDICALE DE FRANCE, 1977, 84 (19): : 2051 - &
  • [37] Familial non-medullary thyroid cancer: clinical features and molecular analysis
    Forde, Claire
    Fussey, John
    Hartley, Claire
    Burghel, George
    Hoffman, John
    Adlard, Julian
    Lalloo, Fiona
    Side, Lucy
    Morrison, Patrick J.
    Smith, Joel
    Dyer, Sara
    Ayuso, Inigo Ortiz de Mendibil
    Lim, Derek
    Evans, Dafydd G. R.
    Maher, Eamonn R.
    Woodward, Emma R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 416 - 416
  • [38] Mixed medullary thyroid cancer and follicular cancer
    Yaturu, Subhashini
    Fontenot, Justin
    Rowland, Tania
    AMERICAN JOURNAL OF CASE REPORTS, 2011, 12 : 1 - 4
  • [39] Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET
    Sahakian, Nicolas
    Castinetti, Frederic
    Romanet, Pauline
    CANCERS, 2023, 15 (19)
  • [40] Molecular Mechanisms of Melatonin for Treating Medullary Thyroid Cancer Using in silico Analysis
    Akbaba, Emel
    ADVANCES IN PHARMACOLOGY AND PHARMACY, 2024, 12 (04) : 430 - 442
12345